Rallybio Corporation (RLYB) Tops Q3 EPS by 56c

Rallybio Corporation (NASDAQ: RLYB) reported Q3 EPS of $0.36, $0.56 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.

You May Also Be Interested In

• EQT And KKKR Said Among Firms Considering Bids For Qiagen - Bloomberg
• XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
• Qiagen names Jonathan Pratt as CEO, replacing Thierry Bernard